All assets associated with the tag: novavax
Novavax and Morrisville-based FUJIFILM Diosynth-Biotechnologies have signed a settlement agreement by which FUJIFILM will receive $185 million. Why?
Starting Monday, Wake County COVID-19 vaccine clinics will feature the Novavax brand vaccine, which uses a protein-based technology to help prevent diseases like shingles, hepatitis B and the flu.
Dr. Rochelle Walensky, director of the US Centers for Disease Control and Prevention, said Tuesday that she has endorsed the recommendation of the agency's vaccine advisers to use the Novavax Covid-19 vaccine as a two-dose primary series in adults.
By Jacqueline Howard and Katherine Dillinger, CNN
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. And there's a North Carolina connection.
A federal advisory committee Tuesday voted to recommend that regulators authorize a COVID-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program.
Carl Zimmer and Rebecca Robbins, New York Times
Novavax recently announced that it would delay its timeline for seeking U.S. authorization for its two-dose COVID-19 vaccine. This leaves thousands of Novavax trial participants stranded when it comes to travel, events and even jobs, because they can't get a different, approved vaccine.
Leslie Moreno, WRAL multimedia journalist
Novavax is looking for more unvaccinated people to participate in trials testing the effectiveness of vaccines and boosters. But those trial participants are running into roadblocks in everyday life.
Novavax, which developed a COVID-19 vaccine that is being manufactured by FUJIFILM Diosynth Biotechnologies, in a Morrisville facility, has announced the vaccine is about 90% effective overall.
As the wait for federal approval to to start vaccinating children against COVID-19 continues, researchers at UNC Health are wasting no time with the Novavax vaccine.
Leslie Moreno, WRAL multimedia jounalist
Novavax is looking for children between the ages of 12 and 17 for its COVID-19 vaccine trial at UNC.